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SUMMARY
Vitamin D insufficiency is a worldwide epidemic affecting billions of individuals, including 
pregnant women and children. Despite its high incidence, the impact of active vitamin D3 
(1,25(OH)D3) on embryonic development beyond osteo-regulation remains largely undefined. 
Here, we demonstrate that 1,25(OH)D3 availability modulates zebrafish hematopoietic stem and 
progenitor cell (HSPC) production. Loss of Cyp27b1-mediated biosynthesis or vitamin D receptor 
(VDR) function by gene knockdown resulted in significantly reduced runx1 expression and 
Flk1+cMyb+ HSPC numbers. Selective modulation in vivo and in vitro in zebrafish indicated that 
vitamin D3 acts directly on HSPCs, independent of calcium regulation, to increase proliferation. 
Notably, ex vivo treatment of human HSPCs with 1,25(OH)D3 also enhanced hematopoietic 
colony numbers, illustrating conservation across species. Finally, gene expression and epistasis 
analysis indicated that CXCL8 (IL-8) was a functional target of vitamin D3-mediated HSPC 
regulation. Together, these findings highlight the relevance of developmental 1,25(OH)D3 
availability for definitive hematopoiesis and suggest potential therapeutic utility in HSPC 
expansion.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Graphical abstract
INTRODUCTION
Characterizing the impact of environmental modifiers on hematopoietic stem and progenitor 
cell (HSPC) formation and maintenance is of significant therapeutic interest because these 
extrinsic factors may influence both the onset and outcome of hematological disease. Active 
vitamin D (1,25(OH)D3), a fat-soluble hormone required for many physiological functions, 
is derived via sunlight and diet in humans. As such, factors including geographical location, 
lifestyle, and nutritional regimen can impact the level of vitamin D sufficiency. Recent 
studies indicate that vitamin D insufficiency is now a global epidemic, affecting over 1 
billion people (Naeem, 2010). Among pregnant women, the worldwide incidence of 
1,25(OH)D3 deficiency is estimated to be between 6% and 96% depending on geographical 
location and availability of supplementation (Weinert and Silveiro, 2015), with a particularly 
high occurrence in industrialized regions (40%–50%) (Bodnar et al., 2007). Severe 
1,25(OH)D3 deficiency because of biosynthetic or signaling pathway mutations results in 
insufficient calcium (Ca2+) absorption and abnormal bone mineralization, leading to rickets 
in children and osteomalacia in adults. Interestingly, case studies of children with severe 
vitamin D deficiency present a variety of hematological disorders (Holick, 2006; Yetgin and 
Ozsoylu, 1982); however, the impact of vitamin D status on embryonic hematopoietic stem 
cell (HSC) production has not been elucidated.
De novo vitamin D synthesis begins with transformation of 7-dehydrocholesterol in the skin 
by UV radiation to the non-active vitamin D precursor cholecalciferol (D3). D3 is then 
modified by cytochrome P450 enzyme 2R1 (CYP2R1), primarily in the liver, to generate 25-
hydroxy vitamin D (25(OH)D3, calcidiol), the circulating form of vitamin D. In the kidney, 
25(OH)D3 is further hydroxylated by CYP27B1 to generate the active metabolite 1,25-
dihydroxy vitamin D (1,25(OH)D3, calcitriol). 1,25(OH)D3 acts as a ligand for the vitamin 
D receptor (VDR), a member of the nuclear hormone receptor family (Mizwicki and 
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Norman, 2009). Upon ligand binding, VDR forms a heterodimer with the retinoic acid X 
receptor (RXR), resulting in nuclear localization and transcriptional regulation of genes with 
vitamin D response elements (VDREs) (Plum and DeLuca, 2010). Genome-wide chromatin 
immunoprecipitation sequencing (ChIP-seq) studies identified more than 200 VDR-
regulated genes (Ramagopalan et al., 2010). 1,25(OH)D3/VDR binding can also elicit non-
genomic responses, including extracellular Ca2+ uptake (Norman, 2006).
In humans, mutations in genes of the vitamin D biosynthetic pathway are the most common 
cause of vitamin D-dependent rickets (VDDR), whereas VDR mutations result in hereditary 
vitamin D-resistant rickets (HVDR) (Holick, 2006). VDDR is treated with vitamin D 
supplementation, whereas HVDR is partially ameliorated with supplemental Ca2+. Children 
with vitamin D deficiency-associated rickets are clinically documented to exhibit a variety of 
hematopoietic defects, including anemia, extramedullary hematopoiesis, thrombocytopenia, 
myelofibrosis, and myelodysplasia. Some features improve with Ca2+ supplementation, 
suggestive of bone marrow (BM) niche dysregulation (Yetgin and Ozsoylu, 1982). Indeed, 
VDR loss in the mouse leads to extramedullary hematopoiesis because of abnormal bone 
mineralization (Jeanson and Scadden, 2010). In contrast, expression analyses indicate that 
VDR is one of 33 genes highly enriched in mouse HSCs (Riddell et al., 2014). VDR levels 
vary as immune cells mature, with monocytes/macrophages showing downregulation 
(Hewison et al., 2003) and T cells upregulation, respectively (Bruce and Cantorna, 2011). 
Subsets of T cells also express Cyp27b1, implying that local 1,25(OH)D3 synthesis may be 
important for T cell function (Ooi et al., 2014). Further, Cyp27b1-null mice show reductions 
in CD4 and CD8 T cells (Panda et al., 2001). Similar to mice, VDR is broadly expressed in 
human hematopoietic cells (Kizaki et al., 1991). Children with von Jaksch-Luzet syndrome, 
a severe vitamin D deficiency, are characterized by anemia with accumulation of 
erythroblasts and myeloblasts resembling chronic myeloid leukemia (Holick, 2006; Kassam 
et al., 1983). Despite multi-lineage abnormalities and frequent childhood onset, minimal 
investigation has been made into the impact of vitamin D status on developmental HSPC 
production.
Unlike adult HSPC homeostasis, which is strongly regulated by interactions with the BM 
microenvironment, embryonic hematopoiesis is initiated de novo in specialized vascular 
niches with transient hematopoietic potential (Carroll and North, 2014). Here we present a 
role for active vitamin D3 in embryonic HSPC production: 1,25(OH)D3 levels directly 
impact HSPC numbers in vivo and in vitro via VDR-mediated regulation of pro-proliferative 
responses independent of Ca2+ flux. Significantly, reduction in 1,25(OH)D3 production or 
function because of perturbations in biosynthetic or signaling genes decreased HSPCs in 
zebrafish embryos. In contrast, 1,25(OH)D3 supplementation expanded HSPCs in vivo and 
in vitro. Gene expression and epistasis studies indicated that 1,25(OH)D3 regulates cxcl8 
(IL-8) signaling to control HSPC numbers. Finally, ex vivo treatment with 1,25(OH)D3 
elicited significant elevations in survival, proliferation, and multi-lineage colony forming 
activity of CD34+ human umbilical cord blood HSCs. Together, these data highlight the 
conservation of 1,25(OH)D3 function in developmental HSC regulation and indicate the 
potential utility of 1,25(OH)D3 supplementation for HSPC expansion in clinical 
transplantation therapies.
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RESULTS
VDR Signaling Is Essential for Hematopoietic Stem and Progenitor Cell Production
Despite case studies of hematological problems in children with severe 1,25(OH)D3 
deficiency, the effects on embryonic hematopoiesis remain uncharacterized. Vitamin D was 
identified as a modulator of HSPC expression in a prior compound screen (North et al., 
2007). We recently showed that accumulation of the inactive vitamin D precursor, 
cholecalciferol, negatively affected hemogenic endothelial formation independent of VDR 
activation by directly antagonizing Hedgehog signaling (Cortes et al., 2015). To investigate 
whether active 1,25(OH)D3-associated VDR signaling impacted definitive hematopoiesis, 
we examined the effect of VDR loss on HSPC development. The zebrafish genome encodes 
two VDRs, vdra and vdrb, with vdra alone acting as the canonical VDR in vivo (Lin et al., 
2012). Fractions from Tg(flk1:dsRed;cmyb:GFP) embryos (1,000 embryos/sample × 3 
replicate sorts) sorted with fluorescence-activated cell sorting (FACS) showed vdra 
expression in endothelial niche cells (Flk1:dsRed+/cMyb:GFP−) and HSPCs (Flk1:dsRed+/
cMyb:GFP+) (Figure S1A). Morpholino (MO) knockdown of vdra strongly reduced runx1 
expression in the aorta-gonad-meso-nephros (AGM) region 36 hr post fertilization (hpf) by 
whole-mount in situ hybridization (WISH) (Figure 1A) without overt defects in the vascular 
niche, as marked by flk1 (Figure 1B) and ephrinb2 (Figure S1B). This result was confirmed 
and quantified by qPCR analysis (runx1, p < 0.01; flk1, p = not significant [N.S.]; ephrinb2, 
p = N.S.) (Figure 1C). In contrast, vdrb knockdown had no effect on runx1 (Figure S1C). 
The specificity of the vdra MO was confirmed by splice product detection (Figure S1E) and 
rescued by addition of vdra, but not vdrb, mRNA (Figure S1F). Importantly, generation of a 
vdra mutant embryo by CRISPR-Cas9 genome editing (Figure S1G and S1H) resulted in the 
same phenotypic effects on both runx1 (decreased) and flk1 (unchanged) by WISH and 
qPCR (runx1, p < 0.01; flk1, p = N.S.; ephrinb2, p = N.S.) (Figures 1D-1F). Whole-embryo 
FACS quantification performed with the Tg(lmo2:GFP;gata1: dsRed) line to mark functional 
erythro-myeloid progenitors (EMPs) (Bertrand et al., 2007) and Tg(flk1:dsRed;cmyb:GFP) 
to mark HSPCs (Bertrand et al., 2010) indicated a 20% (p < 0.05) decrease at 30 hpf (Figure 
S1D) and 38% (p < 0.05) reduction by 48 hpf (Figure 1G), respectively, with vdra 
knockdown. Further, vdra morphants had sustained reductions in CD41:GFP+ HSCs 
colonizing the caudal hematopoietic tissue (CHT) at 72 hpf, as determined by fluorescence 
microscopy (Figure S1I) and FACS (Figure S1J ; p < 0.01). To confirm that the levels of 
vitamin D3/VDR activity correlated with embryonic HSPC output, the impact of reduced 
vitamin D synthesis was also examined. MO knockdown of cyp27b1, which controls the 
final hydroxylation step in 1,25(OH)D3 synthesis, diminished runx1/cmyb expression 
(Figure 1H). FACS analysis of cyp27b1 morphants confirmed a significant decrease (p < 
0.01) in HSPCs (Figure 1I), consistent with a role for 1,25(OH)D3/VDR activity in 
embryonic HSPC production.
Vitamin D Supplementation Stimulates Embryonic HSPC Production
Because vitamin D synthesis and signaling appeared to be necessary for the establishment of 
normal embryonic HSPC numbers, we next examined whether supplementation was 
sufficient to stimulate production. We previously determined that cyp27b1 is expressed by 
12 hpf (Cortes et al., 2015). Exposure to exogenous 25(OH)D3 (10 mM), the circulating 
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form of vitamin D, enhanced runx1/cmyb expression (Figure 2A), which was confirmed and 
quantified as a 2-fold increase in Flk1+/cMyb+ HSPCs by FACS (p < 0.01; Figure 2B). 
Consistent with biosynthetic processing by Cyp27b1 and VDR activation, 25(OH)D3-treated 
embryos had elevated expression of the VDR target cyp24a1 by qPCR at 36 hpf (p < 0.05), 
similar to 1,25(OH)D3 (p < 0.001; Figure 2C). VDR activation was confirmed using a 
Tg(VDRE:mCherry) reporter line that showed enhanced mCherry expression in the AGM 
with both 25(OH)D3 and 1,25(OH)D3 exposure (Figure S2A). Likewise, FACS showed a 
significant increase in Flk1:GPF+/VDRE:mCherry+ cells with 1,25(OH)D3 (p < 0.0001; 
Figure S2B). To further examine correlations between active vitamin D3 levels and HSPC 
production, a dosage analysis was performed. A dose-responsive induction in the 
distribution of embryos with high runx1/cmyb expression was seen with 0.1–10 µM 
1,25(OH)D3 exposure (Figure 2D). FACS quantification further revealed that exposure to 10 
µM 1,25(OH)D3 caused a 25% (p < 0.01) increase in the number of EMPs at 30 hpf (Figure 
S2C) and a 20% (p < 0.01) increase in AGM-derived HSPCs at 48 hpf (Figure 2E). Together 
with enhanced HSPC production, a 2-fold increase in proliferation in the AGM was 
observed with 1,25(OH)D3 treatment (p < 0.001) compared with controls (Figure S2D) 
using the fluorescence ubiquitination cell cycle indicator (FUCCI) reporter Tg(EF1:mAG-
zGEM(1/100) line (Sugiyama et al., 2009) crossed to Tg(flk1:dsred). In contrast, vdra 
knockdown caused a significant decrease in proliferation (p < 0.05; Figure S2E). Finally, to 
determine whether the effect of 1,25(OH)D3 was due to VDR-mediated transcriptional 
regulation or alterations in Ca2+ flux, embryos were treated with the vitamin D3 analog 
calcipotriol, documented to be 100-fold less calcemic than 1,25(OH)D3 (Binderup and 
Bramm, 1988).Calcipotriol (10 µM) shifted the distribution of embryos with increased 
runx1/cmyb expression in a manner phenotypically comparable with 1,25(OH)D3 (Figure 
2F) and caused a 29% elevation in Flk1+cMyb+ HSPCs (p < 0.05) by FACS (Figure 2G). 
Furthermore, the impact of both 1,25(OH)D3 and calcipotriol was sustained in the CHT at 
72 hpf, as determined by microscopy and FACS for CD41:GFP+ (control [con] versus 
1,25(OH)D3, p < 0.05; con versus calcipotriol, p < 0.01) (Figures S2F and S2G). Together, 
these data indicate that vitamin D3-mediated regulation of embryonic HSPC production 
occurs via stimulation of VDR activity and cell proliferation independent of the impact on 
Ca2+ flux.
1,25(OH)D3 Increases Adult HSPC Production and Function In Vivo and In Vitro
Unlike the mammalian BM niche, which is directly affected by vitamin D/VDR-mediated 
Ca2+ flux, adult zebrafish kidney marrow (KM) allows for analysis of 1,25(OH)D3 function 
independent of osteoregulation. To determine whether embryonic modulation of vitamin D 
production or signaling had long-term consequences, KM was dissected and subjected to 
FACS forward scatter (FSC)/side scatter (SSC) profiling (Stachura and Traver, 2016). KM 
from zebrafish exposed to exogenous 1,25(OH)D3 transiently (12–36 hpf) as embryos did 
not differ from control siblings. In contrast, both cyp2r1 and vdra mutants showed 
significant reductions in cells within the “lymphoid” gate (p < 0.05), which includes both 
lymphoid progenitors and HSC (Stachura and Traver, 2016), implying that vitamin D 
sufficiency is necessary to establish normal HSPC numbers (Figures S3A and S3B).
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To investigate whether 1,25(OH)D3 supplementation could stimulate HSPC production in 
the adult, KM irradiation recovery experiments were performed (North et al., 2007). 
Consistent with adverse effects observed in the clinic (Leyssens et al., 2014), systemic 
treatment with 1,25(OH)D3 (10 µM) following irradiation was toxic, likely because of 
hypercalcemia, precluding further analysis. In contrast, exposure to calcipotriol for 24 hr at 2 
days after sub-lethal irradiation caused a significant 34% enhancement (p < 0.01) in the 
recovery of HSPCs on day 10 compared with DMSO-treated controls (Figures 3A and 3B). 
To further characterize the impact of vitamin D3 supplementation, manually isolated whole 
KM was cultured on either zebrafish embryonic stromal trunk (ZEST) cells or zebrafish 
kidney stromal (ZKS) cells (Campbell et al., 2015). After 6 days in culture, a significant 
increase in total hematopoietic cells was observed with 1,25(OH)D3 exposure (ZEST, p < 
0.01; ZKS, p < 0.01) (Figure 3C; Figure S3C), indicative of pro-proliferative stimulation. To 
determine whether 1,25(OH)D3 had a direct impact on HSPC function, methylcellulose 
hematopoietic colony-forming assays were performed (Stachura et al., 2011). Dissociated 
KM plated in the presence of 1,25(OH)D3 (1 × 10−6 M) showed a 40% increase (p < 0.05) 
in total colony forming unit, culture (CFU-C) compared with DMSO controls (Figure 3D) 
on day 10 after plating. Significantly, FACS-sorted CD41:GFP+ KM HSPCs cultured with 
1,25(OH)D3 displayed a similar expansion (1 × 10−6 M, 55% increase, p <0.01; 1 × 10−7 M,
57% increase, p <0.01) (Figure 3E), indicating that adult HSPCs can respond cell-
autonomously to vitamin D3 stimulation to boost HSPC production and function 
independent of osteoregulation.
1,25(OH)D3 Enhances In Vitro Function of CD34+ Human Umbilical Cord Blood
Given the strong pro-HSPC expansion effect observed in vivo and in vitro in zebrafish, we 
next investigated whether the regulatory impact of 1,25(OH)D3 was conserved in 
mammalian HSPCs. VDR is expressed on highly enriched murine HSCs (Riddell et al., 
2014) as well as human CD34+ hematopoietic progenitors (Grande et al., 2002). Expression 
of the human VDR was confirmed in commercially available de-identified whole 
(unfractionated) and CD34+ human umbilical cord blood (hUCB) by qPCR (Figure S4A). 
Ex vivo treatment with 1,25(OH)D3 for 4 hr led to significant upregulation of CYP24A1 in 
both whole (p < 0.0001) and CD34+ (p < 0.05) hUCB cells (Figure 4A), indicative of VDR 
activation. Consistent with pro-proliferative effects in zebrafish, 5-ethyl-2’-deoxyuridine 
(EdU) labeling (10 µM, 1 hr) of whole hUCB cells exposed to 1,25(OH)D3 (1 µM, 4 hr) 
indicated a 35% increase (p < 0.05) in DNA synthesis in the CD34+/CD45lo HSPC 
population compared with controls (Figure 4B). 1,25(OH)D3-treated CD34+ hUCB samples 
also showed significantly decreased cell death (p < 0.05), as determined by FACS for the 
apoptosis marker Annexin V (Figure 4C). To assess whether vitamin D3 would elicit a 
positive impact on in vitro expansion and function of mammalian HSPCs, CFU-C assays 
were performed. Ex vivo incubation of CD34+ hUCB HSCs (n = 5 single donor hUCB units 
split for treatment and plated in replicate) with 1,25(OH)D3 for 4 hr at 37°C increased 
average total colony numbers at 7 days after plating by 38% (p < 0.05) compared with 
matched DMSO-treated controls (Figure 4D). This effect was concentration-dependent, 
where 1 × 10−7 and 1 × 10−6 M elicited a 39% (p < 0.05) and 56% elevation (p < 0.01) in 
colonies, respectively, whereas a higher dose of 1,25(OH)D3 (1 × 10−5 M) was refractory to 
expansion (Figure S4B). Analysis of the differentiation potential on day 10 after plating 
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indicated that each progenitor fraction (colony forming unit, erythroid [CFU-E], colony 
forming unit, granulocyte/monocyte [CFU-GM], and colony forming unit, granulocyte/
erythrocyte/monocyte/megakaryocyte [CFU-GEMM]) was increased by short-term, low-
dose 1,25(OH)D3 exposure (1 × 10−6 M, p < 0.0.05) (Figure 4E). Further, the CFU-GEMM 
population in particular was significantly enhanced (p < 0.05), consistent with an impact on 
multipotent HSPCs.
Because VDR is a known transcriptional regulator, changes in gene expression because of 
1,25(OH)D3 exposure relevant to the observed in vitro hematopoietic phenotypes were 
examined. Response to short-term 1,25(OH)D3 (4-hr) exposure was validated by qPCR, 
where, in addition to enhanced expression of CYP24A1 (Figure 4A), the established VDR 
target and cell cycle regulator G0S2 (Singh et al., 2014), and the anti-apoptotic BCL2 (Vaux 
et al., 1988) were each elevated (Figure S4C). Further, although individual hUCB units 
showed differential responses to vitamin D3 stimulation, both Ingenuity Pathway (IPA) and 
MetaCore analyses revealed overlapping gene networks. In particular, IPA analysis indicated 
“IL-8 signaling” as a significantly regulated canonical pathway, whereas IL-8 (CXCL8) was 
a relevant component of three of the top ten MetaCore networks (Figure 4F; Figure S4D). 
The chemokine CXCL8 was shown previously to contain a functional VDRE in its promoter 
(Ryynänen and Carlberg, 2013) and exhibit an early transcriptional response to 1,25(OH)D3 
stimulation in HL60 cells (Savli et al., 2002). The CXCL8 receptors CXCR1 and CXCR2 
are expressed in hUCB, including the CD34+ fraction (Figure S4E). In response to 
1,25(OH)D3 stimulation, CD34+ hUCB HSCs showed a significant induction in CXCL8 
expression (p < 0.05) (Figure 4G). FACS analysis following monensin treatment to inhibit 
cytokine secretion confirmed a 40% increase (p < 0.01) in CXCL8 protein content in CD34+ 
hUCB cells with 1,25(OH)D3 exposure (Figure 4H), indicating CXCL8 as a relevant VDR 
target in HSPCs.
1,25(OH)D3 Regulates CXCL8 Signaling to Modulate HSPC Production
We recently showed inflammatory activity stimulates developmental HSC production in 
zebrafish and mice (Li et al., 2014). CXCL8 is a potent regulator of chemotaxis, 
proliferation, and survival in the hemato-vascular system in response to inflammatory 
stimuli (de Oliveira et al., 2013). To investigate whether the effect of 1,25(OH)D3 on HSPCs 
was mediated by Cxcl8 signaling, modified epistasis studies were conducted in zebrafish. 
Embryos treated with 1,25(OH)D3 displayed elevated cxcl8 expression, as assessed by 
WISH (Figure 5A) and quantified by whole-embryo qRT-PCR (p <0.05) (Figure 5B). 
Moreover, qRT-PCR analysis of sorted cell fractions showed a 4-fold increase in cxcl8 
expression specifically in Flk1+cMyb+ HSPCs (Figure S5A). Consistent with autocrine or 
paracrine inflammatory stimulation of HSPCs, the Cxcl8 receptors cxcr1 and cxcr2 are 
expressed in the vascular and/or hematopoietic fractions of the embryo (Figure S5B). 
Further, injection of cxcl8 mRNA elicited a dose-dependent expansion in HSPCs (p < 0.05) 
reminiscent of 1,25(OH)D3 treatment (Figure 5C). Use of a previously validated morpholino 
to cxcl8 (Stoll et al., 2011) attenuated the shift in the fraction of embryos with elevated runx/
cmyb expression (Figure 5D) as well as the boost in Flk1+cMyb+ HSPCs mediated by 
1,25(OH)D3 (con versus 1,25(OH)D3, p < 0.05; con versus cxcl8 MO, N.S.; cxcl8 MO 
versus cxcl8 MO + 1,25(OH)D3, N.S.; 1,25(OH)D3 versus 1,25(OH)D3 + cxcl8 MO, N.S.) 
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(Figure 5E), resulting in no difference from controls. Likewise, co-treatment with the 
CXCR1/2 inhibitor SB225002 (White et al., 1998) reduced the overall response of HSPCs to 
1,25(OH)D3 stimulation, as determined by WISH (Figure S5C) and FACS (Figure S5D) 
(con versus 1,25(OH)D3, p < 0.01; 1,25(OH)D3 versus SB25002, p < 0.01; con versus 
1,25(OH)D3 + SB25002, N.S.; 1,25(OH)D3 versus 1,25(OH)D3 + SB25002, N.S.). Cxcl8-
Cxcr1/2 signaling elicits functional responses via activation of a number of intracellular 
mediators. In particular, AKT signaling downstream of Cxcr1/2 stimulation influences 
apoptosis and proliferation (Waugh and Wilson, 2008). Exposure to 1,25(OH)D3 (12–36 
hpf) increased total phosphorylated AKT (pAKT) levels by western analysis (Figure 5F). 
Significantly, this effect was not observed in cxcl8 mutants. Likewise, in vitro exposure to 
the CXCL1/2 inhibitor SB225002 blocked KM HSPC expansion in the context of 
1,25(OH)D3 stimulation in ZEST co-culture assays (Figure 5G) (con versus 1,25(OH)D3, p 
< 0.0001; con versus SB225002, p < 0.05; con versus 1,25(OH)D3 + SB25002, N.S.;
1,25(OH)D3 versus 1,25(OH)D3 + SB25502, p < 0.0001). Finally, co-treatment with 
SB225002 antagonized functional enhancements in KM CFU numbers mediated by 
1,25(OH)D3 or calcipotriol during in vitro methylcellulose culture (Figure 5H) (con versus 
1,25(OH) D3, p < 0.01; con versus calcipotriol, p < 0.01; con versus SB225002, p < 0.05; 
con versus 1,25(OH)D3 + SB25502, N.S.; con versus calcipotriol + SB25502, N.S.). 
Together, our studies demonstrate that CXCL8-CXCR1/2 signaling functions downstream of 
1,25(OH)D3-mediated VDR stimulation to directly regulate HSPC production and 
expansion.
DISCUSSION
Vitamin D has an established role in bone maintenance; severe developmental 1,25(OH)D3 
deficiency results in abnormal bone mineralization (rickets) that can be treated clinically 
with vitamin D2 or D3 supplementation. Interestingly, VDR is expressed in many cell types, 
implying that it may have additional roles in other organs, including the hematopoietic 
system (Christakos et al., 2013; Plum and DeLuca, 2010). However, important differences in 
vitamin D biology and its regulatory impact on mammalian cells have been observed. In 
particular, transcriptional target genes relating to immune regulation are differentially 
regulated by vitamin D in mice compared with humans (Dimitrov and White, 2015). Further, 
vitamin D synthesis in mice is not exclusively dependent on Cyp2r1 as in humans, likely 
explaining the unexpected lack of phenotypes in knockout models (Zhu et al., 2013). In this 
study, we took advantage of the conservation of the vitamin D synthesis and signaling 
pathway in teleosts (Lin et al., 2012) and the amenability of zebrafish to chemical and 
genetic manipulation to characterize the direct impact of 1,25(OH) D3 availability on HSPC 
development. Here we found that active vitamin D3 is both necessary and sufficient to 
modify embryonic HSPC production. Further, we revealed that this effect is due to VDR-
mediated transcriptional activation of the inflammatory chemokine CXCL8, stimulating cell-
autonomous regulation of HSPC expansion and viability via CXCR1/2 activity.
Although CXCL8 is a potent chemo-attractant for neutrophils and functions as part of the 
inflammatory response (Deng et al., 2013), recent studies in zebrafish have indicated that it 
can modulate hematopoietic stem cell formation (Jing et al., 2015). Our findings support a 
model in which vitamin D/VDR-mediated induction of CXCL8 acts in an autocrine/
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paracrine manner to promote HSPC survival and proliferation, similar to its function in 
endometrial stroma cells (Arici et al., 1998). Prior reports indicate that, in contrast to BM 
and mobilized peripheral blood populations, CXCR1 and CXCR2 expression is highly 
enriched in hUCB HSCs (Rosu-Myles et al., 2000), perhaps indicating a fundamental 
difference in responsiveness to CXCL8 signaling between adult and gestational HSPC 
sources. Interestingly, although we observe an increase in CXCL8 expression in both 
zebrafish and hUCB in response to 1,25(OH)D3, the impact of loss of Cxcl8-Cxcr1/2 
signaling was most striking in the setting of vitamin D supplementation. These data imply 
that, although CXCL8 is a functional target of VDR stimulation, additional studies will be 
needed to identify whether other factors can contribute to overlapping or complementary 
aspects of VDR-mediated HSPC regulation in this or other contexts. Our findings also 
expand on the recent appreciation of the important role(s) of pro-inflammatory regulation in 
HSC induction and expansion during embryogenesis (Espín-Palazón et al., 2014; Li et al., 
2014), which may serve as valid targets for therapeutic exploitation as proposed here.
Vitamin D has been investigated previously as a treatment for hematologic malignancy, 
albeit in a different context than presented here. Similar to use of retinoic acid for terminal 
differentiation of blasts in acute promyelocytic leukemia (APL), several in vitro studies 
showed that vitamin D treatment caused differentiation of leukemic precursors to the 
monocytic lineage (Hughes et al., 2010). These findings led to in vivo studies and phase 1 
clinical trials for the use of vitamin D as a differentiation agent for acute myeloid leukemia 
(AML), which ultimately proved to be unsuccessful because of hypercalcemia and 
heterogeneity of the AML subtypes tested (Marchwicka et al., 2014). Interestingly, although 
treatment of the HL-60 leukemia cell line with 1,25(OH)D3 required 18–20 hr of exposure 
for differentiation to begin (Mangelsdorf et al., 1984), an initial burst in proliferation was 
seen during early phases (Brown et al., 1999), similar to the effect on HSPCs observed here. 
Our data indicate that 1,25(OH)D3 stimulates proliferative HSPC expansion. Consistent 
with this role, loss of 1,25(OH)D3 production or VDR function reduced HSPCs in vivo. 
Further, in vitro assays of both CD41 + zebrafish HSCs and CD34+ hUCB HSPCs revealed 
cell autonomous responses to short-term, low-dose 1,25(OH)D3 supplementation, 
independent of the niche, increasing multi-lineage CFU numbers via VDR-mediated 
alterations in proliferation and survival. These data are particularly relevant in the context of 
clinical observations of vitamin D-deficient pediatric and adult HSC transplant recipients 
who demonstrate a poor outcome, including graft versus host disease, delayed time to 
neutrophil engraftment, and overall survival (von Bahr et al., 2015; Wallace et al., 2015). 
Together, our data indicate that, beyond the published effects on lineage differentiation and 
immune-regulation, vitamin D has an important role in the foundation of the hematopoietic 
tree, regulating definitive HSPC numbers in the embryo.
Beyond the evolutionary conservation of 1,25(OH)D3/VDR-mediated regulation of HSPC 
numbers, cord-to-cord variability in our experimental and expression analyses highlight the 
potential clinical relevance of vitamin D status on hUCB function, particularly in regard to 
current ex vivo expansion and transplantation protocols. Vitamin D deficiency is a 
significant problem among pregnant women, ranging from 40%-50% in the northern United 
States (Bodnar et al., 2007). Extrapolating from these numbers, it is safe to assume that 
many hUCB samples are collected from vitamin D-deficient donors. In our hands, we 
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observed variability in the magnitude of HSPC response among the treated hUCB samples, 
which we postulate may be attributed to the vitamin D status of the donor. Because ∼50% of 
transplanted HSC units cause treatment-related complications, including graft failure (10%) 
and/or delayed time to transplant recovery (Singh et al., 2014), there are clearly still 
significant gaps in our understanding of the full array of factors contributing to donor HSPC 
function. In future investigations, it will be of scientific and clinical interest to obtain the 
vitamin D status of the donor (or sample) to determine whether the magnitude of in vitro 
expansion, transplant efficacy, and/or response to 1,25(OH)D3 stimulation depends on the 
original status of the unit. In sum, we have elucidated a fundamental role of vitamin D 
availability in regulating embryonic HSPC production, highlighting the functional potential 
of nutritional vitamin D supplementation for clinical hUCB expansion.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry
Zebrafish lines were maintained and utilized in accordance with the Beth Israel Deaconess 
Medical Center (BIDMC) Institutional Animal Care and Use Committee (IACUC). The 
zebrafish lines used included AB, Tübingen (TU), and mutants and transgenics described in 
the Supplemental Experimental Procedures.
Chemical Treatments
Zebrafish embryos were exposed to chemical modulators in E3 fish medium from 12–36 hpf 
in multi-well plates unless noted otherwise. The following compounds (dose, supplier) were 
used: 1,25(OH)2D3 (1–10 µM, Cayman Chemical), Calcipotriol (1–10 µM, Cayman 
Chemical), SB225002 (1 µM, Cayman Chemical), and 25(OH)D3 (10 µM, Tocris). Treated 
embryos were analyzed by WISH based on established protocols and utilizing published 
probes (Cortes et al., 2015). Phenotypic variation (n ≥ 20 embryos/condition, n ≥ 3 replicate 
clutches) was qualitatively analyzed as relatively high (up), medium (normal), or low (down) 
expression compared with age/stage-matched sibling controls and graphically depicted as 
the percentage falling into each of the three phenotypic expression bins. Normal expression 
reflected the most representative phenotype in the bell curve distribution of each cohort of 
control embryos per experiment. Images were acquired using a Zeiss Axio Imager A1/Axio 
Cam MRC using Axio vision LE software.
Morpholino and mRNA Injection
Translation blocking or splice-site MOs (Gene Tools) against ZF vdra, vdrb, cyp27b1, and 
cxcl8 (Supplemental Experimental Procedures) were injected at the one-cell stage.
Embryo Dissociation and FACS Analysis
Fluorescent embryos (5 embryos/sample × 4 replicates/condition) were dissociated, 
resuspended in × PBS, and analyzed on a BD FACS Canto II in the presence of SYTOX Red 
dead cell stain (5 nM, Life Technologies) as described previously (Cortes et al., 2015). Data 
were analyzed using FlowJo X software (Tree Star). Double-negative, Flk1+/cMyb−, and 
Flk1+/cMyb+ cells were sorted (1,000 embryos/sample × 3 replicate sorts) on a BD SORP 
FACS Aria (BIDMC Flow Cytometry Core).
Cortes et al. Page 10
Cell Rep. Author manuscript; available in PMC 2017 March 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Expression Analysis
Total RNA was purified from zebrafish embryos (40 embryos/condition), human CD34+ 
cells (500,000 cells/condition), or mononuclear UCB (one million cells/condition) using the 
RNAqueous Micro kit (Life Technologies) followed by Turbo DNase-I treatment (Life 
Technologies). For sorted populations, cDNA amplification was performed using the 
NuGEN Ovation Pico WTA2 system. For embryos, 1 µg of total RNA was used to generate 
cDNA using Superscript III First Strand Synthesis Supermix (Life Technologies). 
Superscript VILO mastermix was used for human RNA samples (<1 µg of RNA). 
Quantitative real-time PCR was performed using SYBR Green PCR Master Mix (Life 
Technologies) on a Bio-Rad CFX384 Touch. Samples were run in triplicate with more than 
three biological replicates using published primers (Supplemental Experimental Procedures). 
Data analysis was performed using Real PCR Miner (http://ewindup.info/miner/).
Adult Kidney Marrow Analysis
KM from adult cyp2r1 and vdra mutants and their wild-type (WT) siblings was dissected 
and analyzed by SSC versus FCS FACS profiling after red blood cell lysis as described 
previously (Stachura and Traver, 2016). Irradiation recovery was performed as described 
previously (North et al., 2007). Adult male zebrafish were exposed to 20 Gy of γ-irradiation 
and treated at 2 days post irradiation (dpi) with calcipotriol (20 µM) in the fish water. KM 
was dissected and analyzed at 10 dpi by FACS profiling on a Beckman Coulter Gallios flow 
cytometer (BIDMC Flow Cytometry Core). Percent HSPC recovery was analyzed by FlowJo 
X.
In Vitro Functional Analysis
Hematopoietic in vitro function assays were performed as described previously for zebrafish 
(Campbell et al., 2015; Stachura et al., 2011) and human cells (Goessling et al., 2011) and 
are detailed in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical analyses were performed using Prism 6 (GraphPad). Two-tailed Student’s t tests 
were used for pairwise comparisons and ANOVA for group analyses, with Holm-Sidak post 
hoc tests. Data are represented as mean ± SD. *p < 0.05; ** p < 0.01; ***p < 0.001; N.D., 
not detected.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Developmental 1,25(OH)D3 availability modulates definitive HSPC 
production
• The effect of 1,25(OH)D3 on HSPCs is VDR-mediated and Ca2+-independent
• Vitamin D supplementation significantly increases human UCB HSPCs in 
vitro
• 1,25(OH)D3 exposure promotes viability and proliferation via Cxcl8 (IL-8) 
activity
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In Brief
Cortes et al. elucidate a role for vitamin D signaling in hematopoietic stem and 
progenitor (HSPC) expansion and survival. Using zebrafish embryos and human 
umbilical cord blood, they demonstrate that HSPCs respond directly to 1,25(OH)D3 
stimulation via vitamin D receptor-induced transcriptional activation of the inflammatory 
cytokine CXCL8.
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Figure 1. VDR Is Necessary for Zebrafish Definitive Hematopoiesis
(A) Representative runx1 WISH images and qualitative phenotype distribution (high/
medium/low, n ≥ 30 embryos/condition) of vdra MO-injected embryos and sibling controls 
at 36 hpf. Error bars, mean ± SD.
(B) WISH example and phenotype distribution for flk1 in vdra morphants (n ≥ 20 embryos/
condition).
(C) qPCR analysis quantifying the impact on HSPCs (runx1, **p < 0.01) and hemogenic 
endothelium (flk1, ephrinb2, p = N.S.) in control and vdra morphants (30 embryos/sample 3 
3 replicates).
(D–F) Representative WISH (D), phenotype distributions (E), and qPCR quantification (F) 
in vdra mutant embryos (runx1, **p < 0.01; flk1, ephrinb2, p = N.S.) phenocopied the 
impact on HSPCs but not on vessels.
(G) FACS analysis of vdra morphants indicated significant reductions in Flk1:dsRed+/
cMyb:GFP+ HSPCs (*p < 0.05) at 48 hpf (5 embryos/sample 3 4 replicates/condition). Error 
bars, mean ± SD.
(H) WISH samples and phenotype distribution of runx1/cmyb expression in cyp27b1 MO-
injected embryos at 36 hpf (n ≥ 30 embryos/condition).
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(I) FACS analysis showed a significant decrease in HSPCs (**p < 0.01) with cyp27b1 MO 
injection (n value and error bars as in C).
Scale bars, 100 µm. See also Figure S1.
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Figure 2. 1,25(OH)D3 Regulates HSPC Numbers via Vitamin D Receptor Signaling
(A) Representative runx1/cmyb WISH images and qualitative phenotype distribution 
following 25(OH)D3 exposure from 12–36 hpf (n ≥ 40 embryos/condition).
(B) FACS analysis of 25(OH)D3-treated (10 µM) embryos showed a significant increase in 
HSPCs (**p < 0.01) (5 embryos/sample 3 4 replicates/condition). Error bars, mean ± SD.
(C) qPCR analysis indicated a significant induction in the VDR transcriptional target 
cyp24a1 at 36 hpf after exposure to 25(OH)D3 (*p < 0.05) or 1,25(OH)D3 (***p < 0.001) 
(12–36 hpf) (30 pooled embryos/condition 3 3 replicates).
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(D) Phenotype distribution of runx1/cmyb expression in embryos exposed to increasing 
concentrations of 1,25(OH)D3 from 12–36 hpf (n ≥ 30 embryos/condition).
(E) FACS analysis of 1,25(OH)D3-treated (10 mM) embryos showed a 20% increase in 
HSPCs at 48 hpf (**p < 0.01) compared with controls (n value and error bars as in B).
(F) runx1/cmyb WISH and phenotype distribution after exposure to the non-calcemic 
vitamin D3 analog calcipotriol (n ≥ 30 embryos/condition).
(G) FACS analysis of calcipotriol-treated embryos showed a significantly more HSPCs (*p < 
0.05) at 36 hpf (n value and error bars as in B). Scale bars, 100 µm. See also Figure S2.
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Figure 3. 1,25(OH)D3 Stimulates Cell-Autonomous HSPC Expansion
(A) Representative FACS plots of DMSO- and calcipotriol-treated (20 µM) adult zebrafish at 
10 dpi showing that calcipotriol enhanced the percentage of FSC/SSC-gated HSPCs(n = 9 
adults/condition).
(B) Calcipotriol-treated adults had a 34% (**p < 0.01) increase in HSPCs compared with 
controls at 10 dpi (error bars, mean ± SD) by FACS.
(C) Adult KM HSPCs cultured with 1,25(OH)D3 for 6 days on ZEST cells demonstrated 
increased proliferation (**p < 0.01) compared with controls (n = 3). Error bars, mean ± SD.
(D) Methylcellulose CFU assay of adult whole KM (WKM) cells cultured with of 
1,25(OH)D3 (1 × 10−7 M) displayed a 40% (*p < 0.05) increase in total colonies compared 
with DMSO controls (n = 3). Error bars, mean ± SD.
(E) CFU assay of CD41:GFP+ KM cultured in the presence of 1 × 10−6 and 1 × 10−7M 
1,25(OH)D3 and sorted by FACS showed a 55% (**p < 0.01) and 57% (**p < 0.01) 
elevation, respectively, in colony numbers versus controls (n = 3). Error bars, mean ± SD.
See also Figure S3.
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Figure 4. Ex Vivo 1,25(OH)D3 Exposure Increases hUCB CD34+ HSPCs
(A) qPCR analysis for the known VDR target CYP24A1 showed increased expression 
(****p < 0.0001) in individual whole and CD34+ (*p < 0.05) hUCB units split and treated 
with 1,25(OH)D3 versus DMSO (vehicle) control (n = 3 hUCB units). Error bars, mean ± 
SD.
(B) Whole (umbilical) cord blood (WCB) cells treated with 1,25(OH)D3 (4 hr) had 
significantly increased EdU labeling (*p < 0.05) of CD34+CD45lo HSCs compared with 
matched controls (n = 2). Error bars, mean ± SD.
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(C) Annexin-V/7-AAD FACS analysis of CD34+ hUCB showed a significant decrease (*p < 
0.05, n = 3) in apoptosis with 1,25(OH)D3 treatment.
(D) In vitro methylcellulose assays of CD34+ hUCB treated ex vivo with 1,25(OH)D3 (1 × 
10−6 M) for 4 hr revealed a 38% (*p < 0.05) increase in total CFU numbers compared with 
DMSO controls on day 7 after plating (five independent single donor hUCB samples split 
for treatment and analysis). Error bars, mean ± SD.
(E) 1,25(OH)D3 treatment enhanced all colony types (CFU-E, CFU-GM, and CFU-GEMM) 
on day 10 versus matched controls (ANOVA, p < 0.05), with a significant increase in 
GEMMs (Fisher’s least significant difference [LSD] test, *p < 0.05). n = 5; error bars, ± 
SEM.
(F) Top canonical pathways enriched by 1,25(OH) D3 exposure based on IPA of 
significantly expressed genes. False discovery rate (FDR) < 0.05 (n = 2 single donor CD34+ 
hUCBs); IL-8 (CXCL8). Signaling is highlighted in bold type.
(G) qPCR analysis of CD34+ hUCB cells exposed to 1,25(OH)D3 (4 hr) showed a 
significant increase in CXCL8 expression (*p < 0.05) (n = 3). Error bars, mean ± SD.
(H) FACS quantification for CXCL8 protein content in CD34+ hUCBs showed a significant 
increase with 1,25(OH)D3 treatment (**p < 0.01 n = 4; error bars, mean ± SD).
See also Figure S4.
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Figure 5. 1,25(OH)D3 Mediates HSPC Expansion through CXCL8 Signaling
(A) WISH for cxcl8 showing elevated expression with 1,25(OH)D3 treatment at 36 hpf (n ≥ 
30 embryos/condition).
(B) Whole-embryo qPCR confirmed increased cxcl8 expression at 36 hpf after 1,25(OH)D3 
exposure (*p < 0.05) (40 pooled embryos/condition 3 3 replicates). Error bars, mean ± SD.
(C) FACS analysis of embryos injected with cxcl8 mRNA (100 ng/embryo) showed 
increased Flk1:dsRed+/cMyb:GFP+ HSPCs at 36 hpf (*p < 0.05) (5 embryos/sample × 4 
replicates/condition). Error bars, mean ± SD.
(D) WISH analysis and phenotype distribution indicated that the effect of 1,25(OH)D3 on 
runx1/cmyb expression was diminished in cxcl8 morphants (n ≥ 35 embryos/condition).
(E) FACS analysis of MO-injected embryos treated with 1,25(OH)D3 (con versus 
1,25(OH)D3, *p < 0.05; con versus cxcl8 MO, N.S.; cxcl8 MO versus cxcl8 MO 
+ 1,25(OH)D3, N.S.; 1,25(OH)D3 versus 1,25(OH)D3 +cxcl8 MO, N.S.)(5 embryos/
sample3 4replicates/condition; error bars, mean ± SD) showed that loss of cxcl8 blocked 
vitamin D-mediated HSPC expansion.
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(F) Western blot analysis for pAKT, with AKT as loading control, following 1,25(OH)D3 
stimulation (12–36 hpf) in cxcl8 mutants versus WT siblings (60 embryos/condition).
(G) WKM stromal cell assay documenting changes in proliferation by 1,25(OH)D3 with and 
without co-incubation with SB25002 (con versus 1,25(OH)D3, ****p < 0.0001; con versus 
SB225002, p < 0.05; con versus 1,25(OH)D3 + SB25002, N.S.; 1,25(OH)D3 versus 
1,25(OH)D3 + SB25502, ****p < 0.0001) (n = 4; error bars, mean ± SD).
(H) WKM methylcellulose CFU assay showing fold increase with and without co-treatment 
of 1,25(OH)D3 with SB25002 (con versus 1,25(OH)D3, **p < 0.01; con versus calcipotriol, 
**p<0.01; con versus SB225002, *p < 0.05; con versus 1,25(OH)D3+SB25502, N.S.; con 
versus calcipotriol + SB25502, N.S.).n =4(SB25503 is n = 6); error bars, mean ± SD.
Scale bars, 100 µm. See also Figure S5.
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